Anthony Petrone

Stock Analyst at Mizuho

(1.62)
# 1710
Out of 5,441 analysts
196
Total ratings
Success rate
Average return
37 Stocks
Name Action PT Current % Upside Ratings Updated
HAE Haemonetics
Maintains: Outperform
90 70
52.47 33.41% 12 Aug 8, 2025
LNTH Lantheus Holdings
Maintains: Outperform
120 70
56.07 24.84% 6 Aug 7, 2025
RMD ResMed
Maintains: Outperform
270 290
284.43 1.96% 13 Aug 1, 2025
TFX Teleflex
Maintains: Neutral
130 135
115.98 16.4% 9 Aug 1, 2025
EW Edwards Lifesciences
Maintains: Outperform
87 95
78.21 21.47% 9 Jul 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
140 135
131.33 2.79% 6 Jul 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
105 90
70.89 26.96% 11 Jul 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
17 18
27.29 -34.04% 8 Jul 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
98 100
92.75 7.82% 7 Jul 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
65 70
68 2.94% 9 Jul 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
58 70
33.61 108.27% 7 Jul 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
13 12
12.72 -5.66% 3 Jul 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
95 100
77.88 28.4% 2 Jul 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
60 65
54.81 18.59% 2 Jun 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
200 175
86.99 101.17% 10 Apr 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
2
n/a n/a 1 Apr 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
20
10.11 97.82% 1 Apr 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
60
40.92 46.63% 1 Apr 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
115 120
84.68 41.71% 9 Mar 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
54 58
50.08 15.81% 2 Mar 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
70 60
49.57 21.04% 8 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
100 110
102.78 7.02% 8 Oct 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
12 14
16.41 -14.69% 6 Jun 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
110 105
73.02 43.8% 6 May 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
20 16
5.84 173.97% 3 Apr 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
250 250
79.67 213.79% 6 Mar 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 14
7.05 98.58% 4 Mar 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
350 390
471.96 -17.37% 6 Jan 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
63 67
92.59 -27.64% 2 Aug 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
75
n/a n/a 2 Jul 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
300
381.02 -21.26% 1 Oct 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
200 175
100.02 74.97% 3 Nov 5, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
10.05 99% 1 May 18, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
178
n/a n/a 5 Dec 7, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
30 25
9.77 155.89% 3 May 13, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
25 15
n/a n/a 3 May 22, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Hold
75
n/a n/a 1 Aug 9, 2017